NeuroOne Medical Technologies Corp (nasdaq:NMTC) Share Price

Company Profile

Business description
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Contact
7599 Anagram Drive
Eden PrairieMN55344
USA
T: +1 952 426-1383
https://www.n1mtc.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2026
Employees
18

Recommended

IFM lobs reasonable takeover offer.

Adrian Atkins | 28 April 2026

Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.

Jillian Moore | 28 April 2026

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Ananya Chag | 27 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,915.70	16.00	0.18%
CAC 40	8,072.13	31.96	-0.39%
DAX 40	23,954.56	63.70	-0.27%
Dow JONES (US)	48,825.78	316.15	-0.64%
FTSE 100	10,213.11	119.68	-1.16%
HKSE	26,111.84	432.06	1.68%
NASDAQ	24,609.25	54.55	-0.22%
Nikkei 225	59,917.46	619.90	-1.02%
NZX 50 Index	12,770.30	5.90	0.05%
S&P 500	7,126.59	12.21	-0.17%
S&P/ASX 200	8,687.00	9.40	0.11%
SSE Composite Index	4,107.51	28.88	0.71%